This study investigated the molecular mechanism underlying the anti-proliferative activity of butyrate, a microbiota-derived short-chain fatty acid, in two CRC cell lines, namely HCT116 and SW620, which bear a mutation in β-Catenin and APC, respectively. The gene discussed is APC; the disease is colorectal carcinoma.